Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3077 |
|
Actual shortage: | 235 (8%) | |
Anticipated shortage: | 16 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2817 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-DASATINIB | 20MG | TABLET | Resolved | 2022-12-05 | 2023-03-16 | 177126 |
APO-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2022-12-16 | 2023-01-20 | 178748 |
APO-AMPHETAMINE XR | 20MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-12-23 | 2023-03-23 | 179437 |
APO-PRAVASTATIN | 20MG | TABLET | Resolved | 2022-12-23 | 2023-01-20 | 179459 |
APO-ARIPIPRAZOLE | 20MG | TABLET | Resolved | 2023-01-26 | 2023-03-09 | 182379 |
APO-OLANZAPINE | 20MG | TABLET | Resolved | 2023-02-09 | 2023-06-02 | 184097 |
APO-PANTOPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-03-02 | 2023-04-27 | 185936 |
APO PIROXICAM CAP 20MG | 20MG | CAPSULE | Resolved | 2023-03-16 | 2023-03-23 | 187232 |
APO-OLANZAPINE ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2023-04-06 | 2023-06-02 | 188968 |
APO-FLUOXETINE | 20MG | SOLUTION | Resolved | 2023-04-27 | 2023-05-06 | 190850 |
APO-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2023-05-12 | 2023-06-02 | 192367 |
APO-ESOMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-06-09 | 2023-07-27 | 194568 |
APO-BACLOFEN | 20MG | TABLET | Resolved | 2023-06-29 | 2023-08-04 | 196943 |
APO-LISINOPRIL | 20MG | TABLET | Actual shortage | 2023-07-13 | 2024-04-05 | 198536 |
APO-OLANZAPINE ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2023-07-21 | 2023-11-06 | 199515 |
APO-ROSUVASTATIN | 20MG | TABLET | Resolved | 2023-08-12 | 2023-08-23 | 201710 |
APO-OMEPRAZOLE | 20MG | CAPSULE (DELAYED RELEASE) | Resolved | 2023-08-18 | 2023-09-15 | 202409 |
APO-FOSINOPRIL | 20MG | TABLET | Resolved | 2023-10-06 | 2024-02-16 | 206582 |
APO-LENALIDOMIDE | 20MG | CAPSULE | Resolved | 2023-10-20 | 2023-12-01 | 207695 |
APO-ARIPIPRAZOLE | 20MG | TABLET | Resolved | 2023-11-10 | 2023-12-01 | 209898 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
APO-CETIRIZINE | Discontinued | 2018-05-31 | 2018-05-31 | 50998 | ||
APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-09-07 | 2018-09-15 | 60241 | ||
APO-CYCLOSPORINE ORAL SOLUTION | Discontinued | 2018-09-07 | 2018-09-15 | 60408 | ||
APO-FAMOTIDINE TAB 20MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60477 | ||
APO-FAMOTIDINE TAB 40MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60480 | ||
APO-FENTANYL MATRIX | Discontinued | 2018-09-07 | 2018-09-15 | 60494 | ||
APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
APO-LATANOPROST-TIMOP | Discontinued | 2018-09-07 | 2018-09-15 | 60572 | ||
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60735 | ||
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
APO-RIZATRIPTAN RPD | Discontinued | 2018-09-08 | 2019-04-02 | 60756 | ||
APO-SILDENAFIL R | Discontinued | 2018-09-08 | 2018-09-15 | 60787 | ||
APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-12-21 | 2018-12-24 | 70347 | ||
APO-TIMOP | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
ACID CONTROL | Discontinued | 2019-01-03 | 2019-01-03 | 70906 | ||
APO-OFLOXACIN | Discontinued | 2019-01-03 | 2019-01-03 | 71017 | ||
APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 |